top of page

How do complications from PCOS and OHSS affect the success rate of implantation techniques?

Aashna Vyas
21/11/26

IVF, or in vitro fertilization, is one of the most commonly used assisted reproductive technologies. Even though IVF is effective, standard protocols typically require high doses of hormones for ovarian stimulation. This carries significant risks for patients with Polycystic Ovary Syndrome (PCOS), who are particularly vulnerable to hyper-response. PCOS is a hormonal disorder that causes many small, immature follicles to develop on the ovaries, and because of this, patients with PCOS are more likely to have an exaggerated reaction to ovarian stimulation medications. This raises their risk of Ovarian Hyperstimulation Syndrome (OHSS), a condition in which the ovaries become swollen and painful and can sometimes lead to more serious complications. Because of these risks, many patients and doctors look to IVM (in vitro maturation) as a risk-mitigating option. IVM involves collecting immature eggs from the ovaries and then maturing them in a laboratory. Since this method uses little to no hormonal stimulation, it greatly lowers the chances of OHSS. It also provides a safer alternative for patients who have underlying hormonal sensitivity due to conditions like PCOS by reducing stimulation-related risks. To evaluate these treatments rigorously, this review distinguishes between embryo implantation rates, clinical pregnancy rates, and live-birth rates. Overall, both IVF and IVM are valuable options for patients dealing with PCOS-related infertility and high OHSS risk. These approaches allow doctors to tailor fertility treatments to each patient's needs while reducing risks and supporting safer outcomes.

bottom of page